I agree that this site is using cookies. You can find further informations here.
X
Bhethanabhotla, Sainath
19  results:
Search for persons X
?
1

Late effects in pediatric Hodgkin lymphoma survivors after ..:

Mittal, Abhenil ; Bhethanabhotla, Sainath ; Ganguly, Shuvadeep...
Pediatric Blood & Cancer.  68 (2021)  11 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
2

HL-300: Long-Term Toxicity of ABVD in Paediatric Hodgkin Ly..:

Mittal, Abhenil ; Bhethanabhotla, Sainath ; Ganguly, Shuvadeep...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S249-S250 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Predictors of Poor Response to Salvage Chemotherapy in Rela..:

Bhethanabhotla, Sainath ; Vishnubhatla, Sreenivas ; Sameer, Bakhshi
Annals of the National Academy of Medical Sciences (India).  54 (2020)  - p. 160-170 , 2020
Link: https://doi.org/10.1055/..
 
?
4

Breast Cancer Treatment during the COVID-19 Pandemic:

Batra, Atul ; Mehta, Prashant ; Patel, Amol...
Indian Journal of Medical and Paediatric Oncology.  41 (2020)  2 - p. 135-137 , 2020
Link: https://doi.org/10.4103/..
 
?
5

How I Treat Epithelial Ovarian Cancer during COVID-19 Pande..:

Das, Chandan Krushna ; Mahindru, Shubh ; Patel, Amol...
Indian Journal of Medical and Paediatric Oncology.  41 (2020)  2 - p. 138-140 , 2020
Link: https://doi.org/10.4103/..
 
?
6

How We Treat lung Cancer during SARS-Cov-2 (COVID-19) Pande..:

Biswas, Bivas ; Ganguly, Sandip ; Dabkara, Deepak...
Indian Journal of Medical and Paediatric Oncology.  41 (2020)  2 - p. 149-152 , 2020
Link: https://doi.org/10.4103/..
 
?
7

Colorectal Cancer Chemotherapy during COVID-19 Pandemic:

Bhethanabhotla, Sainath ; Pramanik, Raja ; Srivastava, Priyanka...
Indian Journal of Medical and Paediatric Oncology.  41 (2020)  2 - p. 156-160 , 2020
Link: https://doi.org/10.4103/..
 
?
8

Prognostic Significance of IL-6 in Hodgkin Lymphoma:

Bhethanabhotla, Sainath ; Tiwari, Akash ; Sharma, M. C...
The Indian Journal of Pediatrics.  86 (2019)  6 - p. 551-554 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Presence of risk factors does not affect outcome in early s..:

Bhethanabhotla, Sainath ; Bakhshi, Sameer
Annals of Hematology.  96 (2016)  3 - p. 521-522 , 2016
Link: https://doi.org/10.1007/..
 
?
10

Role of 18F-FDG PET-CT in Monitoring the Cyclophosphamide I..:

Taywade, Sameer Kamalakar ; Kumar, Rakesh ; Bhethanabhotla, Sainath.
Nuclear Medicine and Molecular Imaging.  50 (2015)  3 - p. 261-265 , 2015
Link: https://doi.org/10.1007/..
 
?
11

Cyclophosphamide Followed By Busulphan in Place of Standard..:

Bhethanabhotla, Sainath ; Kumar Sahoo, Ranjit ; Kumar, Lalit..
Biology of Blood and Marrow Transplantation.  21 (2015)  2 - p. S270-S272 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Reply to D. O'Reilly et al:

Patel, Amol ; Gupta, Vineet Govinda ; Biswas, Bivas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162974/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Revisiting Fulvestrant Dosing in Uncertain Economic Times:

Patel, Amol ; Gupta, Vineet Govinda ; Biswas, Bivas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081521/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It P..:

Patel, Amol ; Tannock, Ian F ; Srivastava, Priyanka...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113122/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Role of 18F-FDG PET-CT in Monitoring the Cyclophosphamide I..:

Taywade, Sameer Kamalakar ; Kumar, Rakesh ; Bhethanabhotla, Sainath.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977249/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
1-15